Cytori is developing cell therapies based on autologous adipose-derived regenerative cells (ADRCs) to treat cardiovascular disease and repair soft tissue defects.

Please feel free to contact us directly to learn more about Cytori or the cell therapy industry.

News

May 09, 2013 Cytori Reports First Quarter 2013 Business and Financial Results

May 02, 2013 Cytori to Webcast First Quarter Financial Results on May 9

Apr 10, 2013 Cytori to Present at Regen Med Investor Day 2013 on April 17

Mar 29, 2013 Cytori to Webcast at the Future Leaders in the Biotech Industry Conference on April 5, 2013

Mar 28, 2013 Cytori Patents Method of Treating Renal Diseases Using Adipose-Derived Regenerative Cells